...Phase IIIa Treatment Investigation on...MAX-002 Suppository versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Name
Axcan Pharma
Anticipated Amount
119 000.00
Activity Type
Clinical Trial
Award Type
Contract
Date
January 23, 2011 to August 15, 2011
Award Number
000264-00001
Sponsor Award Number
CD-ME-CAPSITUP508-01
Award Contacts
Name
Lance,Michael P
Title
Principal Investigator
Unit
Cancer Center Division